Demo Day 2026: The Results
Meet the pitching companies
See the companies pitches. Click the button below if you want to find out more about any of these amazing companies.
GEStiC
Provigate
JiMED
CraneBio
Riverfield
FerroptoCure
Sachilles
Aortic Technologies
Splink
Hoshino Lab
ARCS
Lifescapes
RUTEN
Ayumo
Expert Panel of Judges
Seiya Takahashi
Principal at DG Incubation (DGI)
A Principal at DG Incubation (DGI), the venture capital and incubation arm of the Digital Garage Group, working closely with startups to drive innovation.
Shinya Kasuga
General Partner, IT-Farm
IT-Farm is one of Japan’s first cross-border tech VC since 1999, investing in 150 startups across US, Europe, Asia, and Japan.
Gregg Shibata
Sr Principal, Corp-Dev, Blue Shield of California
Gregg Yoshito Shibata (柴田 義人) is a 25-year healthcare veteran who leads strategic investments at Blue Shield of California.
Minoru Sasaki
Director, Nippon Life Global Investors Americas, Inc.
Based in the Silicon Valley office of Nippon Life Global Investors Americas, Inc. (NLGIA), Minoru Sasaki invests in venture capital funds and startups.
Yohichi Sakagawa
Senior Manager, MedVenture Partners
Participated in investments for dozens of companies domestically and internationally, while also supporting corporate open innovation activities. Involved in strategic investment initiatives, including capital and business alliances.
Why Japan? Why Now?
Japanese startups build, but the world rarely sees the results.
Japan's market for medical devices is among the world's largest, and its research base is world class. Its hospitals run some of the highest procedure volumes anywhere. Its engineering culture produces devices with a precision and reliability that clinicians notice immediately.
And yet a striking amount of that innovation never crosses the Pacific. Language, regulatory distance, and a domestic market large enough to be comfortable have kept extraordinary technology inside Japan for years.
That is changing, and this here is the proof. Come and hear founders that are seeing the US as their main target market and building their products for it.
Demo Day is where that starts.
Who is behind this
The Tokyo Silicon Valley MedTech Launchpad (TSVML) is an accelerator with a single focus: bringing Japan's most advanced medical technology to the United States.
We work with startups and founders on the things that actually decide whether a Japanese MedTech company succeeds in America: Product market fit, FDA pathway and regulatory strategy, clinical validation and site relationships, reimbursement, distribution and commercial partnerships, and fundraising from US investors.
Launched in early 2026, our current cohort is 20 companies, ranging from pre-formation spinouts led by professors at Japan's top medical universities through to companies with regulatory approval, revenue and hospital deployments at home.
TSVML is supported by the Tokyo Metropolitan Government as part of its SUTeam program.
